近期，武漢大學(xué)黃衛(wèi)華團(tuán)隊、廈門大學(xué)Christian Amatore團(tuán)隊合作在《Nature Nanotechnology》（IF=38.8）上發(fā)表題為“Nanosensor detection of reactive oxygen and nitrogen species leakage in frustrated phagocytosis of nanofibres”（納米電極監(jiān)測巨噬細(xì)胞受挫性吞噬納米纖維過程中ROS/RNS泄漏）的研究，報告了一種電化學(xué)納米傳感器，用于監(jiān)測和定量表征單個巨噬細(xì)胞對玻璃納米纖維的吞噬作用受阻期間活性物質(zhì)釋放的通量和動態(tài)。
機(jī)體吸入環(huán)境暴露的高長徑比惰性納米纖維（石棉、玻璃纖維、碳納米管等）后，肺泡巨噬細(xì)胞會迅速識別這些異物，并試圖將其吞噬。由于纖維狀材料的高長徑比和難于分解的特性，巨噬細(xì)胞難以將其快速清除，從而形成受挫性吞噬作用（frustrated phagocytosis）。在此過程中，巨噬細(xì)胞內(nèi)的NADPH氧化酶（NOX）和誘導(dǎo)型一氧化氮合酶（iNOS）會持續(xù)產(chǎn)生活性氧和活性氮（ROS/RNS）消化纖維。由于吞噬腔未封閉，大量產(chǎn)生的ROS/RNS可能會從吞噬口泄漏到胞外，對周圍肺組織細(xì)胞造成損傷并引發(fā)疾病。在過去幾十年里，研究人員采用ROS/RNS染色以及活體實驗對碳納米管和石棉等納米纖維材料的研究均支持這一假設(shè)。然而，因缺乏合適的傳感器，該過程中各類活性物質(zhì)的化學(xué)組成及其時空動態(tài)變化特征仍然未知。
針對受挫性吞噬作用假說，研究團(tuán)隊將鉑黑納米線電化學(xué)傳感器（SiC@PtNWS）定位在巨噬細(xì)胞吞噬口處，從而實現(xiàn)對受挫性吞玻璃納米纖維的過程中4種主要ROS/RNS（ONOO-，H2O2，NO和NO2-）泄漏通量的實時定量監(jiān)測。結(jié)果表明，在吞噬各階段，ROS/RNS釋放存在明顯時間差異。相較于細(xì)胞頂部，吞噬口處存在大量ROS/RNS泄漏，且隨吞噬進(jìn)行持續(xù)增加直到吞噬口封閉泄漏。NOX和iNOS參與動態(tài)調(diào)控ROS/RNS的物質(zhì)組成。相關(guān)數(shù)據(jù)定量展示了單個巨噬細(xì)胞受挫性吞噬作用玻璃納米纖維時ROS/RNS產(chǎn)生的時空特征，從而描繪出巨噬細(xì)胞應(yīng)對惰性高長徑納米材料的動態(tài)免疫調(diào)節(jié)過程。體外共培養(yǎng)和活體實驗進(jìn)一步表明，持續(xù)且大量的ROS/RNS泄漏會導(dǎo)致外周細(xì)胞嚴(yán)重受損，最終轉(zhuǎn)化為慢性炎癥和肺損傷。
在該項研究中，使用了欣博盛生物（NeoBioscience Technology Co, Ltd）的QuantiCyto? Mouse IL-1α ELISA kit（小鼠白細(xì)胞介素-1α），用于培養(yǎng)上清液中該細(xì)胞因子含量的測定。
貨號 | 產(chǎn)品名稱 | 靈敏度 | 檢測范圍 |
15.6pg/ml | 31.25-2000pg/ml |
欣博盛生物非常榮幸能夠作為供應(yīng)商為該項研究提供高品質(zhì)ELISA試劑盒，為生物醫(yī)學(xué)領(lǐng)域的科研探索貢獻(xiàn)一份力量。
1. Nanosensor detection of reactive oxygen and nitrogen species leakage in frustrated phagocytosis of nanofibres (Nature Nanotechnology, IF=38.3)
發(fā)表時間：03 January 2024
作 者：Qi Y T, Zhang F L, Tian S Y, et al.
作者單位：武漢大學(xué)
使用產(chǎn)品：Mouse IL-1α ELISA kit
https://pubmed.ncbi.nlm.nih.gov/38172432/
2. Extracellular Matrix-Trapped Bioinspired Lipoprotein Prolongs Tumor Retention to Potentiate Antitumor Immunity (Advanced Materials, IF=29.4）
發(fā)表時間：12 January 2024
作 者：Wu Y, Li Y, Hu Z, et al.
作者單位：上海藥物研究所
使用產(chǎn)品：Mouse TGF-β1, TNF-α, RANTES/CCL5 and IP-10/CXCL10 ELISA kits
https://pubmed.ncbi.nlm.nih.gov/38216153/
3. Pro-Regenerative Glycopeptide Hydrogel Activates Type 2 Immune Response for Wound Healing via Macrophage-T Cell Crosstalk (Advanced Functional Materials, IF=19)
發(fā)表時間：02 January 2024
作 者：Wang J, Liu X, Wang Y, et al.
作者單位：中國醫(yī)學(xué)科學(xué)院
使用產(chǎn)品：Mouse IgG1 ELISA kit
https://onlinelibrary.wiley.com/doi/abs/10.1002/adfm.202307711
4. Gene engineered exosome reverses T cell exhaustion in cancer immunotherapy (Bioactive Materials, IF=18.9)
發(fā)表時間：13 January 2024
作 者：Li P, Xie Y, Wang J, et al.
作者單位：北京大學(xué)
使用產(chǎn)品：Mouse PD1 ELISA kit
https://pubmed.ncbi.nlm.nih.gov/38292412/
5. Targeted mRNA Nanoparticles Ameliorate Blood–Brain Barrier Disruption Postischemic Stroke by Modulating Microglia Polarization (ACS nano, IF=17.1)
發(fā)表時間：16 January 2024
作 者：Gao M, Li Y, Ho W, et al.
作者單位：上海交通大學(xué)
使用產(chǎn)品：Mouse IL-10, TNF-α, and TGF-β ELISA kits
樣本類型：腦組織
https://pubmed.ncbi.nlm.nih.gov/38227975/
6. TS-2021, a third-generation oncolytic adenovirus that carried Ki67 promoter, TGF-β2 5′UTR, and IL?15 against experimental glioblastoma (Journal of Medical Virology, IF=12.7)
發(fā)表時間：January 2024
作 者：Wang J, Zhang J, Zhang Q, et al.
作者單位：首都醫(yī)科大學(xué)北京神經(jīng)外科研究所腦腫瘤研究中心
使用產(chǎn)品：Human IL-15 and MMP-3 ELISA kits
https://pubmed.ncbi.nlm.nih.gov/38149454/
7. Blockage of VEGF function by bevacizumab alleviates early-stage cerebrovascular dysfunction and improves cognitive function in a mouse model of Alzheimer’s disease (Translational Neurodegeneration, IF=12.6)
發(fā)表時間：03 January 2024
作 者：Zhang M, Zhang Z, Li H, et al.
作者單位：中山大學(xué)
使用產(chǎn)品：Mouse VEGF ELISA kit
樣本類型：腦組織
https://pubmed.ncbi.nlm.nih.gov/38173017/
8. DCAF13 inhibits the p53 signaling pathway by promoting p53 ubiquitination modification in lung adenocarcinoma (Journal of Experimental & Clinical Cancer Research, IF=11.3)
發(fā)表時間：02 January 2024
作 者：Wei S, Xing J, Chen J, et al.
作者單位：寧波大學(xué)附屬人民醫(yī)院
使用產(chǎn)品：Normal Goat Serum
https://pubmed.ncbi.nlm.nih.gov/38163876/
9. Curdlan-Decorated Fullerenes Mitigate Immune-Mediated Hepatic Injury for Autoimmune Hepatitis Therapeutics via Reducing Macrophage Infiltration (ACS Applied Materials & Interfaces, IF=9.5)
發(fā)表時間：24 January 2024
作 者：Fei C, Liu L, Qi H, et al.
作者單位：中國科學(xué)院化學(xué)研究所
使用產(chǎn)品：Mouse TNF-α and IL-6 ELISA kits
https://pubmed.ncbi.nlm.nih.gov/38267397/
10. BACH2-mediated CD28 and CD40LG axes contribute to pathogenesis and progression of T-cell lymphoblastic leukemia (Cell Death & Disease, IF=9)
發(fā)表時間：17 January 2024
作 者：Feng M, Zhang B, Li G, et al.
作者單位：中國醫(yī)學(xué)科學(xué)院北京協(xié)和醫(yī)學(xué)院
使用產(chǎn)品：Human IL-6 and IL-8 ELISA kits
https://pubmed.ncbi.nlm.nih.gov/38233409/
11. Targeted delivery of rosuvastatin enhances treatment of HHcy-induced atherosclerosis using macrophage membrane-coated nanoparticles (Journal of Pharmaceutical Analysis, IF=8.8)
發(fā)表時間：13 January 2024
作 者：Liu D, Yang A, Li Y, et al.
作者單位：寧夏醫(yī)科大學(xué)
使用產(chǎn)品：Mouse IL-1β and IL-18 ELISA kits
https://www.sciencedirect.com/science/article/pii/S209517792400025X
12. Tumorous IRE1α facilitates CD8+T cells-dependent anti-tumor immunity and improves immunotherapy efficacy in melanoma (Cell Communication and Signaling, IF=8.4)
發(fā)表時間：30 January 2024
作 者：Yang Y, Wang S, Wang X, et al.
作者單位：空軍軍醫(yī)大學(xué)
使用產(chǎn)品：Human IL-6, TNF-α, MIG/CXCL9, IP-10/CXCL10, I-TAC/CXCL11 ELISA kits
https://pubmed.ncbi.nlm.nih.gov/38291473/
13. Egr-1 is a key regulator of the blood-brain barrier damage induced by meningitic Escherichia coli (Cell Communication and Signaling, IF=8.4)
發(fā)表時間：17 January 2024
作 者：Yang R, Wang X, Liu H, et al.
作者單位：華中農(nóng)業(yè)大學(xué)
使用產(chǎn)品：Mouse VEGF-A and PDGF-BB ELISA kits
樣本類型：腦組織
https://pubmed.ncbi.nlm.nih.gov/38233877/
14. Mi-BMSCs alleviate inflammation and fibrosis in CCl4-and TAA-induced liver cirrhosis by inhibiting TGF-β/Smad signaling (Materials Today Bio, IF=8.2)
發(fā)表時間：24 January 2024
作 者：Shi Q, Xia Y, Wu M, et al.
作者單位：溫州醫(yī)科大學(xué)附屬第一醫(yī)院
使用產(chǎn)品：Mouse HGF and VEGF ELISA kits
https://pubmed.ncbi.nlm.nih.gov/38327975/
15. Antitumor effect of exopolysaccharide from Lactiplantibacillus plantarum WLPL09 on melanoma mice via regulating immunity and gut microbiota (International Journal of Biological Macromolecules, IF=8.2)
發(fā)表時間：January 2024
作 者：Jiang B, Wei M, He Y, et al.
作者單位：南昌大學(xué)
使用產(chǎn)品：Mouse TNF-α, IFN-γ, IL-2 and IL-6 ELISA kits
https://pubmed.ncbi.nlm.nih.gov/37918610/
16. Macrophages promote the transition from myocardial ischemia reperfusion injury to cardiac fibrosis in mice through GMCSF/CCL2/CCR2 and phenotype switching (Acta Pharmacologica Sinica, IF=8.2)
發(fā)表時間：15 January 2024
作 者：Shen S, Xu J, Cheng C, et al.
作者單位：中國科學(xué)技術(shù)大學(xué)
使用產(chǎn)品：Mouse TGF-β and CCL2 ELISA kits
https://pubmed.ncbi.nlm.nih.gov/38225394/
17. Active AKT2 stimulation of SREBP1/SCD1-mediated lipid metabolism boosts hepatosteatosis and cancer (Translational Research, IF=7.8)
發(fā)表時間：18 January 2024
作 者：Huang F, Zhao N, Cai P, et al.
作者單位：中國醫(yī)學(xué)科學(xué)院北京協(xié)和醫(yī)學(xué)院
使用產(chǎn)品：Mouse IL-6 and TNF-α ELISA kits
https://pubmed.ncbi.nlm.nih.gov/38244769/
18. Empagliflozin alleviates the development of autoimmune myocarditis via inhibiting NF-κB-dependent cardiomyocyte pyroptosis (Biomedicine & Pharmacotherapy, IF=7.5)
發(fā)表時間：January 2024
作 者：Lv C, Hu C, Zhu C, et al.
作者單位：華中科技大學(xué)同濟(jì)醫(yī)學(xué)院附屬同濟(jì)醫(yī)院
使用產(chǎn)品：Mouse IL-17, IL-23 and IL-18 ELISA kits
https://pubmed.ncbi.nlm.nih.gov/38042114/
19. LFA-1 regulated by IL-2/STAT5 pathway boosts antitumor function of intratumoral CD8+ T cells for improving anti-PD-1 antibody therapy (Oncoimmunology, IF=7.2)
發(fā)表時間：January 2024
作 者：Shan J, Jing W, Ping Y, et al.
作者單位：鄭州大學(xué)第一附屬醫(yī)院
使用產(chǎn)品：Mouse IFN-γ and IL-2 ELISA kits
https://pubmed.ncbi.nlm.nih.gov/38125721/
20. Lipocalin-2 promotes neutrophilic inflammation in nasal polyps and its value as biomarker (Allergology International, IF=6.8)
發(fā)表時間：January 2024
作 者：Zhang C, Wang H, Hu L, et al.
作者單位：復(fù)旦大學(xué)
使用產(chǎn)品：Human IL-6 and IL-8 ELISA kits
樣本類型：鼻腔組織
https://pubmed.ncbi.nlm.nih.gov/37567832/
21. EBV abortive lytic cycle promotes nasopharyngeal carcinoma progression through recruiting monocytes and regulating their directed differentiation (Plos Pathogens, IF=6.7)
發(fā)表時間：11 January 2024
作 者：Xu X, Zhu N, Zheng J, et al.
作者單位：中山大學(xué)孫逸仙醫(yī)院
使用產(chǎn)品：Human IL-8 ELISA kit
https://pubmed.ncbi.nlm.nih.gov/38206974/
22. Sporopollenin exine capsules modulate the function of microglial cells (Biomaterials Science, IF=6.6)
發(fā)表時間：30 January 2024
作 者：Li M, Hu B, Wu Z, et al.
作者單位：廈門大學(xué)
使用產(chǎn)品：Mouse TNF-αand IL-1β ELISA kits
https://pubmed.ncbi.nlm.nih.gov/38099812/
23. LUBAC promotes angiogenesis and lung tumorigenesis by ubiquitinating and antagonizing autophagic degradation of HIF1α (Oncogenesis, IF=6.2)
發(fā)表時間：25 January 2024
作 者：Jin Y, Peng Y, Xu J, et al.
作者單位：湖北醫(yī)科大學(xué)
使用產(chǎn)品：Mouse VEGF ELISA kit
https://pubmed.ncbi.nlm.nih.gov/38272870/
24. Chemical Composition and Antibacterial and Antiulcerative Colitis Activities of Essential Oil from Pruni Semen (Journal of Agricultural and Food Chemistry, IF=6.1)
發(fā)表時間：03 January 2024
作 者：Wang Y L, Lang D Q, Wu C, et al.
作者單位：南方醫(yī)科大學(xué)
使用產(chǎn)品：Mouse TNF-α ELISA kit
樣本類型：腸組織
https://pubmed.ncbi.nlm.nih.gov/38169317/
25. Effects of unfolding treatment assisted glycation on the IgE/IgG binding capacity and antioxidant activity of ovomucoid (Food & Function, IF=6.1)
發(fā)表時間：02 January 2024
作 者：Xia X, Li J, Liang R, et al.
作者單位：遵義醫(yī)學(xué)院
使用產(chǎn)品：HRP-streptavidin
https://pubmed.ncbi.nlm.nih.gov/38047408/
26. EZY-1 inhibits idiopathic pulmonary fibrosis by regulating M2-type macrophage differentiation (Journal of Functional Foods, IF=5.6)
發(fā)表時間：January 2024
作 者：Wu J, Tu M, Wei T, et al.
作者單位：廣東醫(yī)科大學(xué)附屬醫(yī)院
使用產(chǎn)品：Mouse TGF-β ELISA kit
https://www.sciencedirect.com/science/article/pii/S1756464623005480
27. Multiple bioactivities of choerospondin obtained from blossom of Citrus aurantium L. Var. Amara engl. And its anti-inflammation and anti-atherosclerosis action pathways (Journal of Functional Foods, IF=5.6)
發(fā)表時間：January 2024
作 者：Hao K X, Shen C Y, Zhong R F, et al.
作者單位：華南理工大學(xué)
使用產(chǎn)品：Mouse IL-6, TNF-α and IL-1β ELISA kits
https://www.sciencedirect.com/science/article/pii/S1756464623005418
28. Self-Assembling E2-Based Nanoparticles Improve Vaccine Thermostability and Protective Immunity against CSFV (International Journal of Molecular Sciences, IF=5.6)
發(fā)表時間：02 January 2024
作 者：Song H, Abdullah S W, Pei C, et al.
作者單位：西北農(nóng)林科技大學(xué)
使用產(chǎn)品：Porcine IFN-γ, IL-2 and IL-4 ELISA kits
https://pubmed.ncbi.nlm.nih.gov/38203765/
29. BAFF deficiency aggravated optic nerve crush-induced retinal ganglion cells damage by regulating apoptosis and neuroinflammation via NF-κB-IκBα signaling (International Immunopharmacology, IF=5.6)
發(fā)表時間：05 January 2024
作 者：Lin J, Deng W, Liao J, et al.
作者單位：廣西壯族人民醫(yī)院
使用產(chǎn)品：Human TNF-α, IFN-γ and IL-1β ELISA kits
https://pubmed.ncbi.nlm.nih.gov/38041956/
30. Discovery of a novel pyroptosis inhibitor acting though modulating glutathionylation to suppress NLRP3-related signal pathway (International Immunopharmacology, IF=5.6)
發(fā)表時間：25 January 2024
作 者：Zhou N, Zhang Y, Jiao Y, et al.
作者單位：四川大學(xué)
使用產(chǎn)品：Mouse IL-1β and TNF-α ELISA kits
https://pubmed.ncbi.nlm.nih.gov/38081102/
31. Panax notoginseng saponin R1 improves glucocorticoid-inhibited airway epithelium repair via glucocorticoid receptor β (International Immunopharmacology, IF=5.6)
發(fā)表時間：25 January 2024
作 者：Yang L, Xu M, Zhang L, et al.
作者單位：重慶醫(yī)科大學(xué)
使用產(chǎn)品：Mouse IL-33 and TSLP ELISA kits
樣本類型：肺泡灌洗液
https://pubmed.ncbi.nlm.nih.gov/38104367/
32. PVB exerts anti-inflammatory effects by inhibiting the activation of MAPK and NF-κB signaling pathways and ROS generation in neutrophils (International Immunopharmacology, IF=5.6)
發(fā)表時間：05 January 2024
作 者：Ouyang J, Hong Y, Wan Y, et al.
作者單位：南方醫(yī)科大學(xué)
使用產(chǎn)品：Mouse IL-6 and CXCL-1 ELISA kits
https://pubmed.ncbi.nlm.nih.gov/38006749/
33. Distribution profiles of phenolic compounds in a cultivar of wampee (Clausena lansium (Lour.) Skeels) fruits and in vitro anti-inflammatory activity (Journal of Ethnopharmacology, IF=5.4)
發(fā)表時間：30 January 2024
作 者：Zeng F, Chen M, Yang S, et al.
作者單位：中國熱帶農(nóng)業(yè)科學(xué)院
使用產(chǎn)品：Mouse IL-6 and TNF-α ELISA kits
https://pubmed.ncbi.nlm.nih.gov/37704117/
34. Qi-Zhi-Wei-Tong granules alleviates chronic non-atrophic gastritis in mice by altering the gut microbiota and bile acid metabolism (Journal of Ethnopharmacology, IF=5.4)
發(fā)表時間：30 January 2024
作 者：Chen M, Li Y, Li L, et al.
作者單位：湖北中醫(yī)藥大學(xué)
使用產(chǎn)品：Mouse TNF-α and IL-1β ELISA kits
樣本類型：胃組織;腸道組織
https://pubmed.ncbi.nlm.nih.gov/37838294/
35. Tuberostemonine may enhance the function of the SLC7A11/glutamate antiporter to restrain the ferroptosis to alleviate pulmonary fibrosis (Journal of Ethnopharmacology, IF=5.4)
發(fā)表時間：10 January 2024
作 者：Liu Y, Tang A, Liu M, et al.
作者單位：貴州中醫(yī)藥大學(xué)
使用產(chǎn)品：Mouse IL-1β, IL-2, MCP-1, MIP-2, M-CSF, IL-6, TNF-α and IFN-γ ELISA kits
樣本類型：肺泡灌洗液
https://pubmed.ncbi.nlm.nih.gov/37532076/
36. METTL3 and METTL14 regulate IL-6 expression via RNA m6A modification of zinc transporter SLC39A9 and DNA methylation of IL-6 in periodontal ligament cells (Biochimica et Biophysica Acta (BBA) - Molecular Cell Research, IF=5.1)
發(fā)表時間：January 2024
作 者：Huang J, Wang Y, Zhou Y.
作者單位：武漢大學(xué)口腔醫(yī)學(xué)院
使用產(chǎn)品：Human IL-6 ELISA kit
https://pubmed.ncbi.nlm.nih.gov/37821055/
37. Fusobacterium nucleatum exacerbates the progression of pulpitis by regulating the STING-dependent pathway (The FASEB Journal, IF=4.8)
發(fā)表時間：January 2024
作 者：Zhou L, Mao H Q, Li J Q, et al.
作者單位：武漢大學(xué)
使用產(chǎn)品：Mouse IFN-β ELISA kit
https://pubmed.ncbi.nlm.nih.gov/38085169/
38. Effects of medicine food homologous materials on food allergy-associated factors: intestinal oxidative stress, intestinal inflammation and Th2 immune response (Journal of the science of food and agriculture, IF=4.1)
發(fā)表時間：24 January 2024
作 者：Xu X, Wang Q, Tong P, et al.
作者單位：南昌大學(xué)
使用產(chǎn)品：Human IL-8 ELISA kit
https://pubmed.ncbi.nlm.nih.gov/38268027/
39. Palmitoleic acid protects microglia from palmitate-induced neurotoxicity in vitro (Plos one, IF=3.7)
發(fā)表時間：19 January 2024
作 者：Yu Q, Yang Y, Xu T, et al.
作者單位：浙江海洋大學(xué)
使用產(chǎn)品：Mouse IL-1β ELISA kit
https://pubmed.ncbi.nlm.nih.gov/38241239/
40. The predictive value of serum IL-17A and IL-6 expression in postoperative recurrence in patients with intrauterine adhesion (American Journal of Reproductive Immunology, IF=3.6)
發(fā)表時間：14 January 2024
作 者：Cui X, Xiao H C, Pan W.
作者單位：南京醫(yī)科大學(xué)附屬常州二院
使用產(chǎn)品：Human IL-17A and IL-6 ELISA kits
https://pubmed.ncbi.nlm.nih.gov/38282600/
41. Mouse islet-derived stellate cells are similar to, but distinct from, mesenchymal stromal cells and influence the beta cell function (Diabetic Medicine, IF=3.5)
發(fā)表時間：07 January 2024
作 者：Xu W, Zhou Y, Wang T, et al.
作者單位：徐州醫(yī)科大學(xué)
使用產(chǎn)品：Mouse TGF-β1 and VCAM-1 ELISA kits
https://pubmed.ncbi.nlm.nih.gov/38185936/
42. Fibroblast growth factor 21 predicts arteriovenous fistula functional patency loss and mortality in patients undergoing maintenance hemodialysis (Renal Failure, IF=3)
發(fā)表時間：10 January 2024
作 者：Hu X, Ding H, Wei Q, et al.
作者單位：東南大學(xué)
使用產(chǎn)品：Human FGF-21 ELISA kit
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10783836/
43. Proteomic detection of COX-2 pathway-related factors in patients with adenomyosis (PeerJ, IF=2.7)
發(fā)表時間：15 January 2024
作 者：Zhang J, Shi L, Duan J, et al.
作者單位：鄭州大學(xué)第三附屬醫(yī)院
使用產(chǎn)品：IHC kit
https://pubmed.ncbi.nlm.nih.gov/38239300/
44. Gene polymorphisms of an interleukin-23 receptor associated with susceptibility to rheumatoid arthritis in the Western Chinese Han population (International Journal of Immunogenetics, IF=2.2)
發(fā)表時間：09 January 2024
作 者：Ren R, Tan H, Wang X, et al.
作者單位：四川大學(xué)
使用產(chǎn)品：Human IL-17A ELISA kit
